SY

Sylvain Yon

Chief Executive Officer

iMAb

Paris, Ile-de-France


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
iMAb
Industry
biotechnology
Employees
26.0
Seniority
C suite

Technologies

Outlook Microsoft Office 365 reCAPTCHA Shutterstock Google Maps Mobile Friendly Apache WordPress.org Google Font API Google Tag Manager AI

Keywords

antibody discovery fully human antibody discovery antibody optimization antibody affinity maturation phage display yeast display naive libraries antibody development ph sensitive antibodies therapeutic antibodies monoclonal antibodies multispecific antibodies various antibody formats adc conditional activation drug conjugate in vitro display human antibodies tce bispecific synthetic antibody library gpcr ion channel peptide protein oncology immunooncology inflammation infectious ph-sensitive antibodies antibody-drug conjugates drug targeting therapeutic applications biotechnology protein engineering human synthetic libraries in vitro selection target specificity cytotoxicity assays novel therapeutics pharmaceutical development cancer treatment immunotherapy high-throughput screening ai-driven antibody discovery scaffold optimization binding affinity cross-reactivity tumor microenvironment efficacy & safety binding kinetics customized antibody libraries biomanufacturing clinical trials t cell engagers antibody formats functional validation antibody engineering transmembrane proteins igg antibodies single-chain variable fragments dual technology platform therapeutic index pharmacokinetics next-generation antibody therapies biotherapeutics robust antibody screening partnership opportunities licensing agreements biosimilars biopharmaceutical innovation regulatory approvals hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans